Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $1,651,736 (100.0% shares, 0.0% debt)

Holdings (34)

VTI VANGUARD INDEX FDS 18.2%
Value ($000) $300,982 Shares 1,038,550 Est. Cost $267.51 Unrealized
BN BROOKFIELD CORP 9.7%
Value ($000) $160,793 Shares 2,798,830 Est. Cost $22.16 Unrealized +68.8%
TEM TEMPUS AI INC 8.3%
Value ($000) $137,552 Shares 4,074,419 Est. Cost $30.66 Unrealized +61.3%
EWTX EDGEWISE THERAPEUTICS INC 8.1%
Value ($000) $133,500 Shares 5,000,000 Est. Cost $17.44 Unrealized +82.6%
ASML ASML HOLDING N V 7.0%
Value ($000) $114,938 Shares 165,836 Est. Cost $662.32 Unrealized
CRM SALESFORCE INC 5.9%
Value ($000) $98,260 Shares 293,901 Est. Cost $193.03 Unrealized +64.1%
RXRX RECURSION PHARMACEUTICALS IN 4.1%
Value ($000) $68,375 Shares 10,114,633 Est. Cost $6.72 Unrealized 0.0%
MIRM MIRUM PHARMACEUTICALS INC 3.8%
Value ($000) $62,025 Shares 1,500,000 Est. Cost $12.27 Unrealized +239.7%
PCVX VAXCYTE INC 3.7%
Value ($000) $61,395 Shares 750,000 Est. Cost $31.07 Unrealized +219.6%
INSM INSMED INC 3.0%
Value ($000) $50,031 Shares 724,666 Est. Cost $23.10 Unrealized +211.7%
CRNX CRINETICS PHARMACEUTICALS IN 3.0%
Value ($000) $49,096 Shares 960,215 Est. Cost $19.36 Unrealized +188.9%
VRDN VIRIDIAN THERAPEUTICS INC 2.6%
Value ($000) $43,133 Shares 2,250,000 Est. Cost $16.80 Unrealized +29.4%
AVBP ARRIVENT BIOPHARMA INC 2.5%
Value ($000) $40,510 Shares 1,520,627 Est. Cost $19.60 Unrealized +46.4%
BABA ALIBABA GROUP HLDG LTD 2.3%
Value ($000) $38,353 Shares 452,327 Est. Cost $165.09 Unrealized
PHVS PHARVARIS N V 2.0%
Value ($000) $33,068 Shares 1,725,000 Est. Cost $15.26 Unrealized +34.9%
BMRN BIOMARIN PHARMACEUTICAL INC 1.9%
Value ($000) $32,208 Shares 490,000 Est. Cost $84.22 Unrealized -20.5%
MERUS N V 1.9%
Value ($000) $31,538 Shares 750,000 Est. Cost $57.72 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 1.5%
Value ($000) $25,270 Shares 1,000,000 Est. Cost $37.39 Unrealized -27.3%
CARGO THERAPEUTICS INC 1.5%
Value ($000) $23,991 Shares 1,663,724 Est. Cost $21.33 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.4%
Value ($000) $23,550 Shares 2,500,000 Est. Cost $12.83 Unrealized -19.0%
LANZATECH GLOBAL INC 1.3%
Value ($000) $21,666 Shares 15,814,845 Est. Cost $3.88 Unrealized
BLUEPRINT MEDICINES CORP 0.9%
Value ($000) $15,264 Shares 175,000 Est. Cost $59.75 Unrealized
RCKT ROCKET PHARMACEUTICALS INC 0.8%
Value ($000) $13,827 Shares 1,100,000 Est. Cost $28.09 Unrealized -46.4%
VERVE THERAPEUTICS INC 0.8%
Value ($000) $13,536 Shares 2,400,000 Est. Cost $12.43 Unrealized
ZBIO ZENAS BIOPHARMA INC 0.8%
Value ($000) $13,104 Shares 1,600,000 Est. Cost $17.31 Unrealized -9.9%
CBLL CERIBELL INC. 0.5%
Value ($000) $8,510 Shares 328,809 Est. Cost $27.25 Unrealized 0.0%
FDMT 4D MOLECULAR THERAPEUTICS IN 0.5%
Value ($000) $8,355 Shares 1,500,000 Est. Cost $17.55 Unrealized -55.3%
LXEO LEXEO THERAPEUTICS INC 0.4%
Value ($000) $7,387 Shares 1,122,581 Est. Cost $13.07 Unrealized -39.7%
KYTX KYVERNA THERAPEUTICS INC 0.4%
Value ($000) $6,919 Shares 1,850,000 Est. Cost $19.62 Unrealized -75.6%
MERSANA THERAPEUTICS INC. 0.4%
Value ($000) $6,078 Shares 4,250,000 Est. Cost $1.43 Unrealized
ABCL ABCELLERA BIOLOGICS INC 0.2%
Value ($000) $3,302 Shares 1,126,915 Est. Cost $8.47 Unrealized -67.1%
IOBT IO BIOTECH INC 0.2%
Value ($000) $3,086 Shares 3,354,449 Est. Cost $6.26 Unrealized -84.1%
MQ MARQETA INC 0.1%
Value ($000) $1,674 Shares 441,558 Est. Cost $22.37 Unrealized -80.4%
GLTO GALECTO INC 0.0%
Value ($000) $465 Shares 99,913 Est. Cost $13.05 Unrealized -49.9%